Rezultaty 1 - 20 Rezultaty od 29 Dla wyszukiwania 'Markus Raderer', Czas wyszukiwania: 1,97s
Redukuj rezultaty
-
1
-
2
-
3
-
4
-
5
-
6
Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma od Wolfgang Lamm, Hannes Kaufmann, Markus Raderer, Martha Hoffmann, Andreas Chott, Christoph Zielinski, Johannes Drach
Wydane 2011-07-01
Artykuł -
7
Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna od Philipp Melhorn, Elisabeth Kretschmer-Chott, Ladislaia Wolff, Alexander Haug, Peter Mazal, Markus Raderer, Barbara Kiesewetter
Wydane 2022-11-01
Artykuł -
8
-
9
A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma) od Barbara Kiesewetter, Marlene Troch, Werner Dolak, Leonhard Müllauer, Julius Lukas, Christoph C. Zielinski, Markus Raderer
Wydane 2013-03-01
Artykuł -
10
Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma od Constanze Jonak, Marlene Troch, Barbara Kiesewetter, Julius Lukas, Leonhard Müllauer, Ulrich Jäger, Andreas Chott, Markus Raderer
Wydane 2012-05-01
Artykuł -
11
-
12
-
13
-
14
-
15
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft M... od Marlene Troch, Barbara Kiesewetter, Wolfgang Willenbacher, Ella Willenbacher, Armin Zebisch, Werner Linkesch, Michael Fridrik, Leonhard Müllauer, Richard Greil, Markus Raderer
Wydane 2013-02-01
Artykuł -
16
Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI—Compared with [<sup>18</sup>F]FDG PET/MRI od Xia Lu, Raffaella Calabretta, Wolfgang Wadsak, Alexander R. Haug, Marius Mayerhöfer, Markus Raderer, Xiaoli Zhang, Jingle Li, Marcus Hacker, Xiang Li
Wydane 2022-07-01
Artykuł -
17
Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging. od Ulrika Asenbaum, Richard Nolz, Georgios Karanikas, Julia Furtner, Ramona Woitek, Anton Staudenherz, Daniela Senn, Markus Raderer, Michael Weber, Ingrid Simonitsch-Klupp, Marius E Mayerhoefer
Wydane 2016-01-01
Artykuł -
18
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment od Annarita Conconi, Catherine Thieblemont, Luciano Cascione, Valter Torri, Barbara Kiesewetter, Gloria Margiotta Casaluci, Gianluca Gaidano, Markus Raderer, Franco Cavalli, Armando Lopez Guillermo, Peter W. Johnson, Emanuele Zucca
Wydane 2020-01-01
Artykuł -
19
Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites od Sarah Moody, Joe Sneath Thompson, Shih-Sung Chuang, Hongxiang Liu, Markus Raderer, George Vassiliou, Iwona Wlodarska, Fangtian Wu, Sergio Cogliatti, Alistair Robson, Margaret Ashton-Key, Yingwen Bi, John Goodlad, Ming-Qing Du
Wydane 2018-08-01
Artykuł -
20
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response od Ulrich Jäger, Michael Fridrik, Markus Zeitlinger, Daniel Heintel, Georg Hopfinger, Sonja Burgstaller, Christine Mannhalter, Wilhelm Oberaigner, Edit Porpaczy, Cathrin Skrabs, Christine Einberger, Johannes Drach, Markus Raderer, Alexander Gaiger, Monique Putman, Richard Greil
Wydane 2012-09-01
Artykuł